|
1
|
Butler AE, Janson J, Bonner-Weir S, Ritzel
R, Rizza RA and Butler PC: Beta-cell deficit and increased
beta-cell apoptosis in humans with type 2 diabetes. Diabetes.
52:102–110. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Haataja L, Gurlo T, Huang CJ and Butler
PC: Islet amyloid in type 2 diabetes and the toxic oligomer
hypothesis. Endocr Rev. 29:303–316. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gurlo T, Ryazantsev S, Huang CJ, Yeh MW,
Reber HA, Hines OJ, O'Brien TD, Glabe CG and Butler PC: Evidence
for proteotoxicity in beta cells in type 2 diabetes: Toxic islet
amyloid polypeptide oligomers form intracellularly in the secretory
pathway. Am J Pathol. 176:861–869. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fernández MS: Human IAPP amyloidogenic
properties and pancreatic β-cell death. Cell Calcium. 56:416–427.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Akter R, Cao P, Noor H, Ridgway Z, Tu LH,
Wang H, Wong AG, Zhang X, Abedini A, Schmidt AM and Raleigh DP:
Islet amyloid polypeptide: Structure, function, and
pathophysiology. J Diabetes Res. 2016:27982692016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lavine JA and Attie AD: Gastrointestinal
hormones and the regulation of β-cell mass. Ann N Y Acad Sci.
1212:41–58. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lotfy M, Singh J, Rashed H, Tariq S,
Zilahi E and Adeghate E: Mechanism of the beneficial and protective
effects of exenatide in diabetic rats. J Endocrinol. 220:291–304.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang C, Yuan L and Cao S: Endogenous
GLP-1 as a key self-defense molecule against lipotoxicity in
pancreatic islets. Int J Mol Med. 36:173–185. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lim SW, Jin L, Jin J and Yang CW: Effect
of exendin-4 on autophagy clearance in beta cell of rats with
tacrolimus-induced diabetes mellitus. Sci Rep. 6:299212016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lamont BJ and Andrikopoulos S: Hope and
fear for new classes of type 2 diabetes drugs: Is there preclinical
evidence that incretin-based therapies alter pancreatic morphology?
J Endocrinol. 221:T43–T61. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Göke R, McGregor GP and Göke B: Amylin
alters the biological action of the incretin hormone
GLP-1(7–36)amide. Life Sci. 53:1367–1372. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bak AM, Egefjord L, Gejl M, Steffensen C,
Stecher CW, Smidt K, Brock B and Rungby J: Targeting amyloid-beta
by glucagon-like peptide-1 (GLP-1) in Alzheimer's disease and
diabetes. Expert Opin Ther Targets. 15:1153–1162. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qin Z, Sun Z, Huang J, Hu Y, Wu Z and Mei
B: Mutated recombinant human glucagon-like peptide-1 protects
SH-SY5Y cells from apoptosis induced by amyloid-beta peptide
(1–42). Neurosci Lett. 444:217–221. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Park YJ, Ao Z, Kieffer TJ, Chen H,
Safikhan N, Thompson DM, Meloche M, Warnock GL and Marzban L: The
glucagon-like peptide-1 receptor agonist exenatide restores
impaired pro-islet amyloid polypeptide processing in cultured human
islets: Implications in type 2 diabetes and islet transplantation.
Diabetologia. 56:508–519. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fan R, Li X, Gu X, Chan JC and Xu G:
Exendin-4 protects pancreatic beta cells from human islet amyloid
polypeptide-induced cell damage: Potential involvement of AKT and
mitochondria biogenesis. Diabetes Obes Metab. 12:815–824. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Aston-Mourney K, Hull RL, Zraika S,
Udayasankar J, Subramanian SL and Kahn SE: Exendin-4 increases
islet amyloid deposition but offsets the resultant beta cell
toxicity in human islet amyloid polypeptide transgenic mouse
islets. Diabetologia. 54:1756–1765. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Levine B and Klionsky DJ: Development by
self-digestion: Molecular mechanisms and biological functions of
autophagy. Dev Cell. 6:463–477. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nakai A, Yamaguchi O, Takeda T, Higuchi Y,
Hikoso S, Taniike M, Omiya S, Mizote I, Matsumura Y, Asahi M, et
al: The role of autophagy in cardiomyocytes in the basal state and
in response to hemodynamic stress. Nat Med. 13:619–624. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rivera JF, Costes S, Gurlo T, Glabe CG and
Butler PC: Autophagy defends pancreatic β cells from human islet
amyloid polypeptide-induced toxicity. J Clin Invest. 124:3489–3500.
2014. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Morita S, Sakagashira S, Shimajiri Y,
Eberhardt NL, Kondo T, Kondo T and Sanke T: Autophagy protects
against human islet amyloid polypeptide-associated apoptosis. J
Diabetes Investig. 2:48–55. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Asmar M and Holst JJ: Glucagon-like
peptide 1 and glucose-dependent insulinotropic polypeptide: New
advances. Curr Opin Endocrinol Diabetes Obes. 17:57–62. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bachar-Wikstrom E, Wikstrom JD, Ariav Y,
Tirosh B, Kaiser N, Cerasi E and Leibowitz G: Stimulation of
autophagy improves endoplasmic reticulum stress-induced diabetes.
Diabetes. 62:1227–1237. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mir SU, George NM, Zahoor L, Harms R,
Guinn Z and Sarvetnick NE: Inhibition of autophagic turnover in
β-cells by fatty acids and glucose leads to apoptotic cell death. J
Biol Chem. 290:6071–6085. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xiao J, Li X, Zhao X, He B, Shang X, Han
L, Wu G, Ding X and Zhu T: The effects and mechanism of islet
amyloid polypeptide on insulin secretion in INS-1 cells stimulated
by glibenclamide. Zhonghua Nei Ke Za Zhi. 54:214–218.
2015.PubMed/NCBI
|
|
26
|
Westermark P, Andersson A and Westermark
GT: Islet amyloid polypeptide, islet amyloid, and diabetes
mellitus. Physiol Rev. 91:795–826. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Krizhanovskii C, Fred RG, Oskarsson ME,
Westermark GT and Welsh N: Addition of exogenous sodium palmitate
increases the IAPP/insulin mRNA ratio via GPR40 in human EndoC-βH1
cells. Ups J Med Sci. 122:149–159. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shigeto M, Ramracheya R, Tarasov AI, Cha
CY, Chibalina MV, Hastoy B, Philippaert K, Reinbothe T, Rorsman N,
Salehi A, et al: GLP-1 stimulates insulin secretion by
PKC-dependent TRPM4 and TRPM5 activation. J Clin Invest.
125:4714–4728. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sheng Q, Xiao X, Prasadan K, Chen C, Ming
Y, Fusco J, Gangopadhyay NN, Ricks D and Gittes GK: Autophagy
protects pancreatic beta cell mass and function in the setting of a
high-fat and high-glucose diet. Sci Rep. 7:163482017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fujitani Y, Kawamori R and Watada H: The
role of autophagy in pancreatic beta-cell and diabetes. Autophagy.
5:280–282. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhao X, Liu G, Shen H, Gao B, Li X, Fu J,
Zhou J and Ji Q: Liraglutide inhibits autophagy and apoptosis
induced by high glucose through GLP-1R in renal tubular epithelial
cells. Int J Mol Med. 35:684–692. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang J, Wu J, Wu H, Liu X, Chen Y, Wu J,
Hu C and Zou D: Liraglutide protects pancreatic β-cells against
free fatty acids in vitro and affects glucolipid metabolism in
apolipoprotein E-/- mice by activating autophagy. Mol Med Rep.
12:4210–4218. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Shigihara N, Fukunaka A, Hara A, Komiya K,
Honda A, Uchida T, Abe H, Toyofuku Y, Tamaki M, Ogihara T, et al:
Human IAPP-induced pancreatic β cell toxicity and its regulation by
autophagy. J Clin Invest. 124:3634–3644. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Guo H, Wang B, Li H, Ling L, Niu J and Gu
Y: Glucagon-like peptide-1 analog prevents obesity-related
glomerulopathy by inhibiting excessive autophagy in podocytes. Am J
Physiol Renal Physiol. 314:F181–F189. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cai X, Li J, Wang M, She M, Tang Y, Li J,
Li H and Hui H: GLP-1 treatment improves diabetic retinopathy by
alleviating autophagy through GLP-1R-ERK1/2-HDAC6 signaling
pathway. Int J Med Sci. 14:1203–1212. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ferdaoussi M, Abdelli S, Yang JY, Cornu M,
Niederhauser G, Favre D, Widmann C, Regazzi R, Thorens B, Waeber G
and Abderrahmani A: Exendin-4 protects beta-cells from
interleukin-1 beta-induced apoptosis by interfering with the c-Jun
NH2-terminal kinase pathway. Diabetes. 57:1205–1215. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kim MH, Kim EH, Jung HS, Yang D, Park EY
and Jun HS: EX4 stabilizes and activates Nrf2 via PKCδ,
contributing to the prevention of oxidative stress-induced
pancreatic beta cell damage. Toxicol Appl Pharmacol. 315:60–69.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zeng Z, Yu R, Zuo F, Zhang B, Ma H and
Chen S: Recombinant Lactococcus lactis expressing bioactive
exendin-4 to promote insulin secretion and beta-cell proliferation
in vitro. Appl Microbiol Biotechnol. 101:7177–7186. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Petersen M, Hofius D and Andersen SU:
Signaling unmasked: Autophagy and catalase promote programmed cell
death. Autophagy. 10:520–521. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhu J, Wang KZ and Chu CT: After the
banquet: Mitochondrial biogenesis, mitophagy, and cell survival.
Autophagy. 9:1663–1676. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Law BY, Wang M, Ma DL, Al-Mousa F,
Michelangeli F, Cheng SH, Ng MH, To KF, Mok AY, Ko RY, et al:
Alisol B, a novel inhibitor of the sarcoplasmic/endoplasmic
reticulum Ca(2+) ATPase pump, induces autophagy, endoplasmic
reticulum stress, and apoptosis. Mol Cancer Ther. 9:718–730. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Abedini A and Schmidt AM: Mechanisms of
islet amyloidosis toxicity in type 2 diabetes. FEBS Lett.
587:1119–1127. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ahrén B, Winzell MS, Wierup N, Sundler F,
Burkey B and Hughes TE: DPP-4 inhibition improves glucose tolerance
and increases insulin and GLP-1 responses to gastric glucose in
association with normalized islet topography in mice with
beta-cell-specific overexpression of human islet amyloid
polypeptide. Regul Pept. 143:97–103. 2007. View Article : Google Scholar : PubMed/NCBI
|
